U.S. Pharmaceuticals & Biotech Breakout Stocks

Legend Biotech

Market Cap: US$6.7b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

ArriVent BioPharma

Market Cap: US$1.4b

A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

Absci

Market Cap: US$926.1m

A clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States.

Replimune Group

Market Cap: US$824.1m

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer.

Rezolute

Market Cap: US$478.5m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

ACC Aviation Holdings

Market Cap: US$249.4m

Engages in the development of cannabis powder products.

Elicio Therapeutics

Market Cap: US$230.5m

A clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.

Q32 Bio

Market Cap: US$206.7m

A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.

EOM Pharmaceuticals Holdings

Market Cap: US$25.3m

A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.

Quantum Genesis AI

Market Cap: US$16.0m

A biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing.

Enzolytics

Market Cap: US$4.6m

A drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

Rimrock Gold

Market Cap: US$865.2k

Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.

Neutra

Market Cap: US$608.6k

Researches, develops, and provides hemp-derived products in the nutraceutical space in the United States.

Allstar Health Brands

Market Cap: US$210.1k

A specialty health care products company, focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over the counter remedies in the Americas.

GB Sciences

Market Cap: US$158.8k

A plant-based research and biopharmaceutical drug development company.

Affymax

Market Cap: US$89.4k

Does not have significant operations.

Hero Technologies

Market Cap: US$56.4k

Operates as an early-stage cannabis company.

Plandaí Biotechnology

Market Cap: US$44.9k

Does not have significant operations.

Anthera Pharmaceuticals

Market Cap: US$26.2k

A biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs.

Scopus BioPharma

Market Cap: US$25.3k

A clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs.